MULTIPLE-SCLEROSIS - PATHOLOGY OF RECURRENT LESIONS

被引:197
|
作者
PRINEAS, JW
BARNARD, RO
REVESZ, T
KWON, EE
SHARER, L
CHO, ES
机构
[1] UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, NEWARK, NJ 07103 USA
[2] NATL HOSP, LONDON WC1N 3BG, ENGLAND
关键词
D O I
10.1093/brain/116.3.681
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent autopsy studies suggest that remyelinated shadow plaques located in otherwise intact white matter are the outcome of a previous single episode of acute demyelination. In the present study, of 98 remyelinated plaques examined in 15 patients with multiple sclerosis who died between 27 days and 5 years after clinical onset, 15 showed evidence of a superimposed new demyelinating lesion. Inspection of old shadow plaques in a separate series of patients with subacute and long-standing multiple sclerosis revealed that such lesions sometimes exhibit punched-out areas of demyelination and gliosis similar in size and shape to fresh lesions located within or overlapping remyelinated shadow plaques. The findings support magnetic resonance imaging evidence that local recurrence may be as important or more important than progressive edge activity in determining plaque growth and the conversion of nascent lesions into classical demyelinated plaques. The findings also support experimental evidence that recurrent demyelination of the same area of white matter may be one of the factors underlying failed remyelination in multiple sclerosis.
引用
收藏
页码:681 / 693
页数:13
相关论文
共 50 条
  • [21] PATHOLOGY OF MULTIPLE-SCLEROSIS - SOME NEW DEVELOPMENTS
    RICHARDSON, EP
    CLINICAL NEUROSCIENCE, 1994, 2 (3-4) : 253 - 257
  • [22] PATHOLOGY AND PATHO-PHYSIOLOGY OF MULTIPLE-SCLEROSIS
    HERNDON, RM
    SEMINARS IN NEUROLOGY, 1985, 5 (02) : 99 - 106
  • [23] THE EVOLUTION OF MULTIPLE-SCLEROSIS LESIONS ON SERIAL MR
    GUTTMANN, CRG
    AHN, SS
    HSU, LG
    KIKINIS, R
    JOLESZ, FA
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1995, 16 (07) : 1481 - 1491
  • [24] EVIDENCE OF LESIONS NOT CLINICALLY DETECTABLE IN MULTIPLE-SCLEROSIS
    GRAVELEAU, P
    NOUVELLE PRESSE MEDICALE, 1982, 11 (17): : 1293 - 1293
  • [25] FIBRONECTIN (FN) IN MULTIPLE-SCLEROSIS (MS) LESIONS
    SOBEL, RA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1989, 48 (03): : 324 - 324
  • [26] IMMUNOPATHOLOGIC FEATURES OF RETINAL LESIONS IN MULTIPLE-SCLEROSIS
    LUCARELLI, MJ
    PEPOSE, JS
    ARNOLD, AC
    FOOS, RY
    OPHTHALMOLOGY, 1991, 98 (11) : 1652 - 1656
  • [27] PARAMETRIC ANALYSIS OF LESIONS OF MULTIPLE-SCLEROSIS BY MRI
    RUMBACH, L
    ARMSPACH, JP
    GOUNOT, D
    COLLARD, M
    CHAMBRON, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 283 - 283
  • [28] EXPRESSION OF THE CYTOKINE RANTES IN MULTIPLE-SCLEROSIS LESIONS
    HVAS, J
    SINDING, K
    BERNARD, CCA
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 124 - 124
  • [29] MULTIPLE-SCLEROSIS LESIONS OF THE AUDITORY PONS ARE NOT SILENT
    LEVINE, RA
    GARDNER, JC
    FULLERTON, BC
    STUFFLEBEAM, SM
    FURST, M
    ROSEN, BR
    BRAIN, 1994, 117 : 1127 - 1141
  • [30] ATYPICAL DEMYELINATING LESIONS IN PATIENTS WITH MULTIPLE-SCLEROSIS
    YETKIN, Z
    HAUGHTON, VM
    NEURORADIOLOGY, 1995, 37 (04) : 284 - 286